Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Avg
|
|
New words:
aboutTysabrifor, Abraxane, accessingTysabritherapy, ADDF, additionalTysabridata, AGM, AMT, andAzactam, Anglo, antipsychotic, anxiety, ARYx, Asia, attacking, attain, attention, atypical, AzactamandMaxipime, AzactamandMaxipimein, AzactamandMaxipimerepresented, BACE, bapineuezumab, benchmarking, betting, biomarker, BioScience, bore, CA, Cardizem, Cebix, chain, chairmanship, chance, charity, Chicago, CMC, commodity, compulsive, consortium, consummate, cope, corroborated, Counselor, counteracting, CR, creation, creative, Delaware, desk, desperately, devote, devoted, difficulty, disagree, dislocation, downgraded, driven, DTA, dutch, Easy, EEPP, elucidate, Empowering, endeavor, entirety, Enzyme, ER, expenditure, extreme, FacilityLocated, fampridine, fault, fibrilization, flat, fluvoxamine, forTysabriand, Fox, fromAzactamincreased, fromMaxipimedecreased, fromTysabri, fulfill, GA, gaming, GMP, Greencore, hard, hierarchy, ICAD, Icarom, Ideal, illiquid, illiquidity, inaccurate, inhibitor, insoluble, insulin, interventional, intramuscular, inTysabrifor, IP, Janssen, Jazz, jury, LA, lab, Laboratory, landscape, launchedTysabrifor, learned, leverage, literacy, literate, live, living, lose, lowest, LUVOX, Madrid, maleate, mandatory, Matrix, maximizing, Mayo, McKinsey, Michael, mission, mitigated, modulating, Montreal, NanoCrystal, nanometer, NAV, Neuropsychiatry, nongovernmental, nonrecurring, NY, obsessive, Octubre, ofMaxipimefollowing, ofMaxipimehave, ofPrialtEuropean, ofPrialtincreased, ofRule, ofTysabrimore, oldest, orderly, ourMaxipimeandAzactam, outflow, outlook, outreach, overtaken, PA, Paddy, paliperidone, palmitate, Pasarow, passuwith, Pasteur, Pat, Patrick, Paya, plasma, population, postponement, productMaxipimeexpired, promptly, proprietaryNanoCrystaltechnology, proven, qualification, quickly, Readymix, recession, recurrence, redesign, rescue, reset, residential, restart, revealed, Ritalin, Rochester, Roundtable, Royal, Scaleable, scientist, shifting, Society, solution, sophisticated, SR, stable, StatementNo, steadfastly, suggest, tailored, tenure, toAzactamandMaxipime, Tokyo, TysabriROW, unadjusted, unavoidable, underscored, uninsured, unobservable, unsuccessful, USA, valuable, verdict, virtually, widespread, withmild, withTysabritherapy, workforce, wrote, yearly
Removed:
addressing, adjunctive, adjustment, Alan, Albert, alleging, allergic, ambulatory, amend, Andrx, appellate, approvedPrialtfor, asserting, begin, behavior, branding, buyer, Cambridge, Cardinal, categorize, CBE, cell, comparison, compensating, competitor, comprising, confusion, continuation, convert, Cornell, counterparty, Cranfield, crystalline, cured, damaged, defendant, directed, discovering, disruption, distinguished, Einstein, EL, Emisphere, EPIL, eventually, exacerbate, exchanged, expensing, faculty, fell, forced, formed, forTysabricovering, gastrointestinal, gather, Gillespie, Glaxo, governor, harm, Hulme, immunization, inherently, intolerant, introduced, investigating, Iomai, Japanese, Karen, Kim, language, lecturer, lengthen, Lieberburg, locate, Lusk, Luton, MAC, MBA, McKesson, Medtronic, mental, Miami, mistakenly, morphine, mount, Mt, neurobiology, nursing, older, onAzactamexpired, optimal, owed, passu, personality, pharmacology, pharmacy, physiology, play, pleading, postdoctoral, prepayment, pressure, profound, pump, reaction, recommendation, refractory, remanded, remitting, repatriate, reversed, Rockefeller, save, Schenk, segmental, shorter, Sinai, skilled, span, stability, Sterling, strict, suffer, SynchroMed, systemic, toTysabriintellectual, tract, trafficking, transact, transactional, trauma, unconditionally, undistributed, unexercised, unsecured, upheld, waiver, warranted, Wellcome, Wellesley, Westmeath, withdrawn, Yednock, Yen
Filing tables
Filing exhibits
Elan similar filings
Filing view
External links
Exhibit 13.1
Certification Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report onForm 20-F for the period ending December 31, 2008 (the “Report”) of Elan Corporation, plc (the Company), as filed with the Securities and Exchange Commission on the date hereof, I, G. Kelly Martin, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
This certification accompanies this Report pursuant to section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.
/s/ G. KELLY MARTIN
G. Kelly Martin
Chief Executive Officer
Date: February 26, 2009